BIOTRONIK Announces First Enrollment in CRT-Next Study

BIOTRONIK has announced first enrollment in a multicenter study that aims to demonstrate that a two-lead cardiac resynchronization therapy (CRT) system with atrial sensing is at least as effective as a conventional three-lead system. BIOTRONIK's CRT-DX technology provides therapy through two ventricular leads and features a floating dipole for complete atrial diagnostics without an additional lead.
Source: eHealth News EU - Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news